RS
LMAT icon

R Squared’s LeMaitre Vascular LMAT Stock Holding History

R Squared’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Sell
2,571
-59
-2% -$5.62K 0.15% 221
2025
Q4 		$213K Sell
2,630
-503
-16% -$43.3K 0.1% 339
2025
Q3 		$274K Buy
+3,133
New +$280K 0.12% 283
2025
Q1 		– Sell
-190
Closed -$17.5K – 950
2024
Q4 		$17.5K Buy
+190
New +$18.3K 0.02% 944

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

R Squared's LMAT Position: Q1 2026 in Review

R Squared reduced its LeMaitre Vascular (LMAT) stake by 2.2% in Q1 2026, selling an estimated $5.62K and leaving 2,571 shares worth $281K. The position accounts for 0.15% of the portfolio, ranked #221.

R Squared first reported a position in LMAT in Q4 2024 and has held it in 4 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • R Squared held 2,571 shares of LeMaitre Vascular worth $281K as of Q1 2026.
  • R Squared sold 59 LeMaitre Vascular shares in Q1 2026, an estimated $5.62K.
  • LeMaitre Vascular made up 0.15% of R Squared's portfolio in Q1 2026, its #221 holding.
  • R Squared first reported a position in LeMaitre Vascular in Q4 2024 and has held it in 4 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.